Endoscope-associated infections remain one of the most stubborn problems in sterile processing, despite more than a decade of revised guidelines from AAMI, the CDC, and device manufacturers. The gap between published protocol and bedside practice continues to surface in surveillance data and recall notices alike.
What the Data Shows
Surveillance studies consistently point to manual cleaning as the most failure-prone step in the reprocessing cycle. Channel brushing, often performed under time pressure between procedures, is the stage most frequently associated with residual bioburden on post-cleaning verification tests.
Automated endoscope reprocessors have reduced variability, but they cannot compensate for inadequate pre-cleaning. If biofilm forms before a scope reaches the AER, high-level disinfection chemistry may not fully penetrate it.
Where Facilities Are Falling Short
Three recurring issues appear across audit reports:
- Inconsistent leak testing before immersion
- Drying and storage cabinets not maintained to manufacturer specification
- Staff turnover outpacing competency verification cycles
None of these are new problems. What has changed is the volume of procedures performed per scope per day, which compresses the time available for each reprocessing cycle.
The Path Forward
Some institutions have begun borescope inspection of channels as a verification step beyond visual inspection alone. Early adopters report catching residual debris that passed standard visual checks. Wider adoption remains limited by cost and training requirements.